ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025
Federated learning with multi-cohort real-world data for predicting the progression from mild cognitive impairment to Alzheimer's disease.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Multimodal AI for Alzheimer Disease Diagnosis: Systematic Review of Datasets, Models, and Modalities.Journal of medical Internet research · 2026Pooled it
- Unlocking multi-institutional insights into disease progression with PEAL as a lossless, one-shot federated learning solution.NPJ digital medicine · 2026Article
- Characterizing Alzheimer's Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record-Based Data.Clinical pharmacology and therapeutics · 2026Article
- Artificial intelligence-driven nano-enhanced stem cell therapy for neurodegenerative diseases: from rational design to clinical translation.Journal of nanobiotechnology · 2026Review
- Glycyrrhizic acid-loaded biomimetic hybrid liposomes targeting inflammatory cascades and PD-1/PD-L1 pathway to reverse neuroinflammation-driven cognitive decline.Materials today. Bio · 2026Article
- FEDI-CODE: A federated and causally-informed framework for dementia risk prediction using multi-site patient data.PloS one · 2026Article
- Normalizing flow based neural processes for Alzheimer's disease progression prediction.PloS one · 2026Article
- Review
- Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions.Acta pharmaceutica Sinica. B · 2025Review
- Federated learning with multi-cohort real-world data for predicting the progression from mild cognitive impairment to Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionLeveraging routinely collected electronic health records (EHRs) from multiple health-care institutions, this approach aims to assess the feasibility of using federated learning (FL) to predict the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD).
methodsWe analyzed EHR data from the OneFlorida+ consortium, simulating six sites, and used a long short-term memory (LSTM) model with a federated averaging (FedAvg) algorithm. A personalized FL approach was used to address between-site heterogeneity. Model performance was assessed using the area under the receiver operating characteristic curve (AUC) and feature importance techniques.
resultsOf 44,899 MCI patients, 6391 progressed to AD. FL models achieved a 6% improvement in AUC compared to local models. Key predictive features included body mass index, vitamin B12, blood pressure, and others. DISCUSSION: FL showed promise in predicting AD progression by integrating heterogeneous data across multiple institutions while preserving privacy. Despite limitations, it offers potential for future clinical applications. HIGHLIGHTS: We applied long short-term memory and federated learning (FL) to predict mild cognitive impairment to Alzheimer's disease progression using electronic health record data from multiple institutions. FL improved prediction performance, with a 6% increase in area under the receiver operating characteristic curve compared to local models. We identified key predictive features, such as body mass index, vitamin B12, and blood pressure. FL shows effectiveness in handling data heterogeneity across multiple sites while ensuring data privacy. Personalized and pooled FL models generally performed better than global and local models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.